MikeTrendsTrends right now

search

Food and Drug Administration

Trends

  1. 1
    Former FDA chief says cyclosporiasis outbreak not fully controlled▼Cyclosporiasis outbreak not 'fully under control,' former FDA chief says✉newsHealthPandemics39 min ago

    A former commissioner of the US Food and Drug Administration says the ongoing cyclosporiasis outbreak is not 'fully under control.' Cyclosporiasis is an intestinal infection caused by a parasite, often linked to contaminated fresh produce, causing diarrhea and flu-like illness. The warning suggests officials have not yet contained the spread or identified its full source, keeping food-safety concerns in the spotlight.

  2. 2
    Raw milk cheese recalled amid E. coli outbreak, FDA says▼Raw milk cheese recalled over E. coli outbreak, FDA says✉newsHealthPandemics39 min ago

    US health regulators have announced a recall of raw milk cheese linked to an ongoing E. coli outbreak. The Food and Drug Administration says the cheese is suspected of making people ill, and retailers are being urged to pull affected products from shelves. News outlets across the country are carrying the recall notice, warning consumers who bought raw milk cheese to check products and avoid eating them while the investigation continues.

  3. 3

    Reports say the US Food and Drug Administration has approved the first mRNA-based flu vaccine, marking a new application of the technology widely used in COVID-19 vaccines. The trending term reflects news headlines about the decision. Beyond the headline itself, the available posts contain no further details on the vaccine's maker, availability, or public reaction, so what people are saying beyond sharing the news is not clear from the posts.

  4. 4
    FDA nominee Heidi Overton stonewalls Senate committee questions●"Republicans and Democrats alike on the Senate Health, Education, Labor and Pensions Committee tried repeatedly with litMmastodonWorldUS Politics47 h ago

    Members of both parties on the Senate Health, Education, Labor and Pensions Committee repeatedly pressed the White House's nominee to lead the Food and Drug Administration, Heidi Overton, for her views on health policy. Lawmakers tried several times to draw out opinions or commitments but got little in return, drawing bipartisan frustration at the confirmation hearing.